KAITLYN SMITH: Open Payments
NPI 1083034946 · RANDOLPH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 14 payments from 6 companies in 2025. Trend: 2023 $320 · 2024 $317 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $141 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| PFIZER INC. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: DALVANCE, ZERBAXA, EMBLAVEO, TEFLARO, ELIQUIS, UBRELVY, TREMFYA, NUZYRA.
Industry payments across NJ — which companies pay providers there.
